Comparison

CDR2 Polyclonal Antibody

Item no. E-AB-11068-60
Manufacturer Elabscience
Amount 60 uL
Quantity options 120 uL 20 uL 200 uL 60 uL
Category
Type Antibody Polyclonal
Applications IHC
Specific against Human (Homo sapiens), Mouse (Murine, Mus musculus)
Host Rabbit
Isotype IgG
Conjugate/Tag Unconjugated
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias AA617262, CDR 2, CDR 62, CDR2, CDR2, CDR62, Cerebellar degeneration related protein 2 62kDa, Cerebellar degeneration related protein 2, Cerebellar degeneration related protein, Cerebellar degeneration-related protein 2, Major Yo paraneoplastic antigen, MGC116181, MGC144810, MGC144811, Paraneoplastic cerebellar degeneration associated antigen, Paraneoplastic cerebellar degeneration-associated antigen, PCD 17, PCD17, RGD1310578, Yo, Yo paraneoplastic antigen
Similar products CDR2, Paraneoplastic cerebellar degeneration-associated antigen, PCD17, Cerebellar degeneration-related protein 2, Major Yo paraneoplastic antigen, CDR62, Yo, Yo paraneoplastic antigen, CDR 2, CDR 62, Cerebellar degeneration related protein 2, Cerebellar degeneration related protein, Paraneoplastic cerebellar degeneration associated antigen, PCD 17, AA617262, Cerebellar degeneration related protein 2 62kDa, MGC116181, MGC144810, MGC144811, RGD1310578
Shipping Condition Cool pack
Hazard information Comply with cargo safety certificate
Available
Manufacturer - Category
Primary Antibodies
Manufacturer - Targets
CDR2
Shipping Temperature
The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.
Storage Conditions
Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Manufacturer - Research Areas
Cancer, Immunology
Background
CDR2 (cerebellar degeneration-related protein 2), also referred to as Yo or CDR62, is a 545 amino acid protein that is associated with the development of paraneoplastic cerebellar degeneration (PCD). PCD, an immune-mediated syndrome, belongs to a heterogeneous group of rare paraneoplastic neurologic disorders affecting the neurological system. PCD is characterized by subacute cerebellar ataxia and occurs mainly in patients with ovarian, uterine, fallopian tube or breast cancer.
Concentration
0.4 mg/mL
Buffer
PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Purification Method
Affinity purification
Recommended Dilution
IHC 1:50-1:200
Santa Cruz #
sc-109228
Abbreviation
CDR2
Clonality
Polyclonal
Immunogen
Recombinant protein of human CDR2
Category ID III
Polyclonal Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 60 uL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?